185 related articles for article (PubMed ID: 16336516)
1. QT interval prolongation and arrhythmia: an unbreakable connection?
Anderson ME
J Intern Med; 2006 Jan; 259(1):81-90. PubMed ID: 16336516
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias?
Anderson ME
Trends Cardiovasc Med; 2004 May; 14(4):152-61. PubMed ID: 15177266
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents.
Li J; Marionneau C; Zhang R; Shah V; Hell JW; Nerbonne JM; Anderson ME
Circ Res; 2006 Nov; 99(10):1092-9. PubMed ID: 17038644
[TBL] [Abstract][Full Text] [Related]
4. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome.
Qi X; Yeh YH; Chartier D; Xiao L; Tsuji Y; Brundel BJ; Kodama I; Nattel S
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):295-304. PubMed ID: 19808480
[TBL] [Abstract][Full Text] [Related]
5. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
Anderson ME
Pharmacol Ther; 2005 Apr; 106(1):39-55. PubMed ID: 15781121
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced QT-interval prolongation: considerations for clinicians.
Li EC; Esterly JS; Pohl S; Scott SD; McBride BF
Pharmacotherapy; 2010 Jul; 30(7):684-701. PubMed ID: 20575633
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E; Watson T; Lip GY
Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
[TBL] [Abstract][Full Text] [Related]
9. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability).
Hondeghem LM
Novartis Found Symp; 2005; 266():235-44; discussion 244-50. PubMed ID: 16050272
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cardiac Na(+) and Ca(2+) currents by CaM and CaMKII.
Wagner S; Maier LS
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S26-S33. PubMed ID: 16686679
[TBL] [Abstract][Full Text] [Related]
11. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
[TBL] [Abstract][Full Text] [Related]
12. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.
Wu Y; Temple J; Zhang R; Dzhura I; Zhang W; Trimble R; Roden DM; Passier R; Olson EN; Colbran RJ; Anderson ME
Circulation; 2002 Sep; 106(10):1288-93. PubMed ID: 12208807
[TBL] [Abstract][Full Text] [Related]
13. CaMKII and its role in cardiac arrhythmia.
Erickson JR; Anderson ME
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1332-6. PubMed ID: 18803570
[TBL] [Abstract][Full Text] [Related]
14. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
15. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
17. Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus.
Anderson ME
Cardiovasc Res; 2007 Mar; 73(4):657-66. PubMed ID: 17254559
[TBL] [Abstract][Full Text] [Related]
18. QT prolongation is an unreliable predictor of ventricular arrhythmia.
Hondeghem LM
Heart Rhythm; 2008 Aug; 5(8):1210-2. PubMed ID: 18675236
[TBL] [Abstract][Full Text] [Related]
19. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
[TBL] [Abstract][Full Text] [Related]
20. CaM kinase inhibition: apply directly to the heart?
London B
Circ Res; 2006 Nov; 99(10):1027-8. PubMed ID: 17095730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
